Client cases
How we work in practice
These cases show the Liberi approach in practice. We value a tailored and personal approach with every client.
Client cases
Selected client cases
Client case
Partnering in Pre-Candidate Selection stage
The successful licensing agreement had an immediate and lasting impact on our client. Securing a partnership with a globally recognized pharmaceutical company validated the asset’s potential and significantly
Read the case »
Client case
Biotech Valuation
By providing a rigorous and transparent value assessment, we enabled the client to approach potential investors with a clear understanding of their worth, empowering them to negotiate from
Read the case »
Client case
Pharma Out-licensing Phase I asset
If there is interest from the industry, Liberi is able to achieve results fast and have its clients enter confidential reviews in matter of weeks.
Read the case »
Client case
In-licensing project
A detailed example of a business case where Liberi Group supported their client with licensing-in promising assets
Read the case »
Track record
Deals our clients have announced
Full track record

Evaluation
Lexaria Bioscience
with PharmCo (undisclosed pharma)
Agreement to evaluate DehydraTECH with PharmCo’s proprietary molecules, with a path to licensing

Option
Rumi Scientific
with Enthorin Therapeutics
Option to license RTX-7340, an IND-ready PDE2 inhibitor for Fragile X syndrome


Licensing
IMPACT Therapeutics
with Pharmanovia
Senaparib in 66 countries, up to €423.5 million in total deal value
Want results like these?
Book a call to discuss your asset or project with our team.

